Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AHB-137 in CHB Treated With Nucleos(t)ide Analogues
NCT06993480Phase 2Active, not recruiting
- Sponsor
- AusperBio
- Start
- Jul 2025
- Primary completion
- Jul 2027
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of AHB-137 in Chronic Hepatitis B (CHB), sponsored by AusperBio. Started Jul 2025; status: active, not recruiting.
02
Drugs
AHB-137
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT06993480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06993480.